We are live on ! Find out more
ZCM

Zebra Capital Management Portfolio holdings

AUM $20M
1-Year Est. Return 2.24%
This Fund
S&P 500
This Quarter Est. Return
+15.53%
1 Year Est. Return
+2.24%
3 Year Est. Return
+142.1%
5 Year Est. Return
+107.07%
10 Year Est. Return
+252.16%
AUM
$28.6M
AUM Growth
+$2.31M
Cap. Flow
-$765K
Cap. Flow %
-2.68%
Top 10 Hldgs %
38.6%
Holding
92
New
11
Increased
10
Reduced
46
Closed
25

Top Buys

Rank Stock Value
1
VB icon
Vanguard Morningstar Small-Cap ETF
VB
+$2.25M
2
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$2.24M
3
HRMY icon
Harmony Biosciences
HRMY
+$243K
4
ALEX
Alexander & Baldwin
ALEX
+$214K
5
SHOO icon
Steven Madden
SHOO
+$208K

Top Sells

Rank Stock Value
1
FOR icon
Forestar Group
FOR
+$467K
2
PATK icon
Patrick Industries
PATK
+$431K
3
PAHC icon
Phibro Animal Health
PAHC
+$380K
4
PTCT icon
PTC Therapeutics
PTCT
+$268K
5
MYGN icon
Myriad Genetics
MYGN
+$261K

Sector Composition

Rank Sector Weight
1 Healthcare 14.78%
2 Technology 14.16%
3 Consumer Discretionary 11.67%
4 Financials 8.99%
5 Industrials 8.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDXG icon
76
MiMedx Group
MDXG
$602M
– –
-40,206
Closed -$116K
MYGN icon
77
Myriad Genetics
MYGN
$270M
– –
-13,672
Closed -$261K
OFIX icon
78
Orthofix Medical
OFIX
$477M
– –
-10,901
Closed -$208K
ORGO icon
79
Organogenesis Holdings
ORGO
$305M
– –
-59,481
Closed -$193K
PAHC icon
80
Phibro Animal Health
PAHC
$1.47B
– –
-28,625
Closed -$380K
PATK icon
81
Patrick Industries
PATK
$2.74B
– –
-14,754
Closed -$431K
PTCT icon
82
PTC Therapeutics
PTCT
$5.64B
– –
-5,331
Closed -$268K
RBBN icon
83
Ribbon Communications
RBBN
$377M
– –
-11,215
Closed -$25K
RBCAA icon
84
Republic Bancorp
RBCAA
$1.95B
– –
-5,379
Closed -$206K
TG icon
85
Tredegar Corp
TG
$265M
– –
-11,446
Closed -$108K
TILE icon
86
Interface
TILE
$1.99B
– –
-10,749
Closed -$97K
TOI icon
87
The Oncology Institute
TOI
$486M
– –
-27,484
Closed -$127K
VEL icon
88
Velocity Financial
VEL
$689M
– –
-10,908
Closed -$118K
VNDA icon
89
Vanda Pharmaceuticals
VNDA
$307M
– –
-14,975
Closed -$148K
LBC
90
DELISTED
Luther Burbank Corporation Common Stock
LBC
– –
-19,428
Closed -$226K
TIG
91
DELISTED
Trean Insurance Group, Inc. Common Stock
TIG
– –
-37,741
Closed -$128K
SPNE
92
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
– –
-16,319
Closed -$92K
1 2 3
4

Similar funds

CM
Cartica Management Washington, District of Columbia $20.9M AUM 14.51% 1-Year Est. Return
NPAM
Noble Path Asset Management New York $14.6M AUM 3.07% 1-Year Est. Return
6C
6elm Capital New York $33.3M AUM 34.31% 1-Year Est. Return
SCU
Spinnaker Capital (UK) London England, United Kingdom $5.4M AUM 7.99% 1-Year Est. Return
FFG
Ford Financial Group Fresno, California $2.36M AUM 7.29% 1-Year Est. Return
KE
KLP Enterprises Branford, Connecticut $1.97M AUM
GFT
Gilfoyle Foundation Trust New Fairfield, Connecticut $100 AUM
CCM
CTC Capital Management Chicago, Illinois $47.8M AUM 5.18% 1-Year Est. Return

Zebra Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Zebra Capital Management held 92 positions worth $28.6M, up 8.8% from $26.3M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Zebra Capital Management's Q4 2022 filing shows 11 new, 10 increased, 46 reduced and 25 closed positions. Its largest new stake was Vanguard Morningstar Small-Cap ETF: 12,130 shares worth $2.23M. The largest sale was Forestar Group, an estimated $467K.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 20% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Zebra Capital Management's largest Q4 2022 buy was Vanguard Morningstar Small-Cap ETF: 12,130 shares worth $2.23M.
  • Zebra Capital Management added most to Halozyme in Q4 2022, an estimated $40.2K increase.
  • Zebra Capital Management's biggest Q4 2022 reduction was Scansource, cutting an estimated $217K.
  • Zebra Capital Management fully exited Forestar Group in Q4 2022, selling an estimated $467K.
  • Zebra Capital Management's ten largest holdings make up 39% of its $28.6M portfolio in Q4 2022.
  • Zebra Capital Management opened 11 new positions and closed 25 in Q4 2022.
  • Zebra Capital Management's portfolio value rose 8.8% quarter-over-quarter to $28.6M.

Based on Zebra Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.